Glenn Matfin

Aspects of drug development and clinical trials — Part 1
The British Journal of Diabetes & Vascular Disease 2007 7: 97-98. [PDF] [References]  

Glenn Matfin

Review: Biomarkers in clinical trials and drug development: measurement of cardiometabolic risk
The British Journal of Diabetes & Vascular Disease 2007 7: 101-106. [Abstract] [PDF] [References]  

Gabriele E Sonnenberg, Glenn Matfin, and Rickey R Reinhardt

Review: Drug treatments for obesity: where are we heading and how do we get there?
The British Journal of Diabetes & Vascular Disease 2007 7: 111-117. [Abstract] [PDF] [References]  

Richard E Pratley and Glenn Matfin

Review: Pre-diabetes: clinical relevance and therapeutic approach
The British Journal of Diabetes & Vascular Disease 2007 7: 120-129. [Abstract] [PDF] [References]  

David R Matthews

Why we need a new model for diabetes care
The British Journal of Diabetes & Vascular Disease 2007 7: 130-131. [Abstract] [PDF] [References]  

Ian W Campbell and Caroline Day

Sitagliptin — enhancing incretin action
The British Journal of Diabetes & Vascular Disease 2007 7: 134-139. [Abstract] [PDF] [References]  

Sunil Zachariah, Osman Sharfi, Ben Burton, Stephen Spencer Nussey, and Gul Bano

Diabetic papillopathy diagnosed on retinal screening in an asymptomatic patient
The British Journal of Diabetes & Vascular Disease 2007 7: 140-141. [PDF] [References]  

Anthony S Wierzbicki

Voodoo medicine — cardiovascular trials jinxed in New Orleans: Dr Anthony Wierzbicki discusses highlights of the 56th Annual Scientific Session of American College of Cardiology held at Morial Conventions Centre in New Orleans March 24th—27th, 2007
The British Journal of Diabetes & Vascular Disease 2007 7: 142-144. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.